Live feed20:13:35·757dINSIDERFilingvia QuantisnowBiotech Target N V bought $587,500 worth of shares (250,000 units at $2.35), increasing direct ownership by 24% to 1,279,820 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.MTEM· Molecular Templates Inc.Health CareOriginal source